Article
Cancer genomics and inherited risk.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Mar 2014
Stadler Zsofia K, Schrader Kasmintan A, Vijai Joseph, Robson Mark E, Offit Kenneth
Abstract excerpt
Next-generation sequencing (NGS) has enabled whole-exome and whole-genome sequencing of tumors for causative mutations, allowing for more accurate targeting of therapies. In the process of sequencing the tumor, comparisons to the germline genome may identify variants associated with susceptibility to cancer as well as other hereditary diseases. Already, the combination of massively parallel sequencing and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
